tbuckley/cabot-search huggingface dataset:
Underrepresentation of Older Adults in Clinical Trials of Chimeric Antigen Receptor (CAR) T-Cell Therapy for Hematologic Malignancies: An FDA Analysis
Authors: Pamela Seam, Upendra Mahat, Najat Bouchkouj, Poornima Sharma, Helka Peredo-Pinto, Mona Elmacken, Megha Kaushal, Yuxia Jia, Shu Wang, Zhiheng Xu, Yvette Kasamon, Bindu Kanaparu, Nicholas Richardson, Nicole Gormley
Journal: Blood (2023)
A NUDT15 Genetic Polymorphism Study in Adult Acute Leukemia Patients Integrating Pharmacogenomics and Clinical Practice: A Single Centre Experience from South India
Authors: Thomas Babu, Logesh Durairaj, Aditya Sanjeevi, Jeyasankar Subramanian, Uddiptya Goswami, Deepak George, Cecili Stanislasus, Nirusha Muralitharan, Vani K M, Sooraj Ratnakumar, Jose M Easow
Journal: Blood (2023)
A Prospective Observational Study Evaluating Extracellular Water to Total Body Water Ratio By Using the Bioelectrical Impedance Analysis in Elderly Patients with Hematologic Malignancies
Authors: Hitomi Nakayama, So Okubo, Kohei Shinmura, Shuhei Kurosawa, Aki Sakurai, Chisako Ito, Yoshinobu Aisa, Tomonori Nakazato
Journal: Blood (2023)
Training in basic gastrointestinal endoscopic procedures: a European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastroenterology and Endoscopy Nurses and Associates (ESGENA) Position Statement
Authors: Giulio Antonelli, Andrei M. Voiosu, Katarzyna M. Pawlak, Tiago Cúrdia Gonçalves, Nha Le, Michiel Bronswijk, Marcus Hollenbach, Omar Elshaarawy, Ulrike Beilenhoff, Pietro Mascagni, Theodor Voiosu, Maria Pellisé, Mário Dinis-Ribeiro, Konstantinos Triantafyllou, Marianna Arvanitakis, Raf Bisschops, Cesare Hassan, Helmut Messmann, Ian M. Gralnek
Journal: Endoscopy (2023)

Main Statements This ESGE Position Statement provides structured and evidence-based guidance on the essential requirements and processes involved in training in basic gastrointestinal (GI) endoscopic procedures. The document outlines definitions; competencies required, and means to their assessment and maintenance; the structure and requirements of training programs; patient safety and medicolegal issues. 1 ESGE and ESGENA define basic endoscopic procedures as those procedures that are commonly indicated, generally accessible, and expected to be mastered (technically and cognitively) by the end of any core training program in gastrointestinal endoscopy. 2 ESGE and ESGENA consider the following as basic endoscopic procedures: diagnostic upper and lower GI endoscopy, as well as a limited range of interventions such as: tissue acquisition via cold biopsy forceps, polypectomy for lesions ≤ 10 mm, hemostasis techniques, enteral feeding tube placement, foreign body retrieval, dilation of simple esophageal strictures, and India ink tattooing of lesion location. 3 ESGE and ESGENA recommend that training in GI endoscopy should be subject to stringent formal requirements that ensure all ESGE key performance indicators (KPIs) are met. 4 Training in basic endoscopic procedures is a complex process and includes the development and acquisition of cognitive, technical/motor, and integrative skills. Therefore, ESGE and ESGENA recommend the use of validated tools to track the development of skills and assess competence. 5 ESGE and ESGENA recommend incorporating a multimodal approach to evaluating competence in basic GI endoscopic procedures, including procedural thresholds and the measurement and documentation of established ESGE KPIs. 7 ESGE and ESGENA recommend the continuous monitoring of ESGE KPIs during GI endoscopy training to ensure the trainee’s maintenance of competence. 9 ESGE and ESGENA recommend that GI endoscopy training units fulfil the ESGE KPIs for endoscopy units and, furthermore, be capable of providing the dedicated personnel, infrastructure, and sufficient case volume required for successful training within a structured training program. 10 ESGE and ESGENA recommend that trainers in basic GI endoscopic procedures should be endoscopists with formal educational training in the teaching of endoscopy, which allows them to successfully and safely teach trainees.
Improving Outcomes of Peripheral Blood Stem Cell (PBSC) HLA-Mismatched Unrelated Donor (MMUD) Hematopoietic Cell Transplantation (HCT): Effect of Graft Versus Host Disease (GVHD) Prophylaxis
Authors: Vaibhav Agrawal, Dongyun Yang, Sally Mokhtari, Tamer Othman, Yazeed Samara, Amanda Blackmon, Hoda Pourhassan, Brian J. Ball, Idoroenyi Amanam, Shukaib Arslan, Salman Otoukesh, Paul B. Koller, Karamjeet S. Sandhu, Ibrahim Aldoss, Haris Ali, Amandeep Salhotra, Ahmed Aribi, Andrew Artz, Pamela S. Becker, Vinod Pullarkat, Forest Marc Stewart, Eileen Patricia Smith, Anthony Stein, Guido Marcucci, Stephen J. Forman, Ryotaro Nakamura, Monzr M. Al Malki
Journal: Blood (2023)
Evaluating Blinatumomab Treatment Adoption in Varied Resource Settings Using the RE-AIM Framework
Authors: Caitlyn Duffy, Zehra Fadoo, Niharendu Ghara, Victor Santana, Hiroto Inaba, Sima Jeha, Yichen Chen, Linh Pham, Hyun Jy Chung, Meenakshi Devidas, Nickhill Bhakta, Heather Brandt
Journal: Blood (2023)
Time without Transfusion Reliance or Anemia Worsening: A Novel Method for Integrating Transfusion Dependence, Anemia, and Survival with Myelofibrosis Therapies Based on the Phase 3 Simplify-1 and Simplify-2 Trials
Authors: Ruben A. Mesa, Moshe Talpaz, Flora Mazerolle, Boris Gorsh, Manal M'Hari, Antoine Regnault, Catherine Ellis, Zhaohui Wang, Molly Purser, Tom Liu, Bryan Strouse, Dwaipayan Patnaik
Journal: Blood (2023)
Disparities in Genetic Profiles, Risk Stratification and Outcomes in Adults with Acute Myeloid Leukemia Comparing Patients of Hispanic and Non-Hispanic Ethnicity in Central California
Authors: Omar Mahmood, Tanjot Saini, Daniel Park, Sundeep Bekal, Inderpreet Bal, Simran Saini, Tabark Altai, Yousef Fayed, Yueqi Yan, Haifaa Abdulhaq
Journal: Blood (2023)
Mitoxantrone Hydrochloride Liposome, Bortezomib, and Dexamethasone- Based Regimen in Multiple Myeloma Patients with Extramedullary Plasmacytoma: A Pilot Study
Authors: Yuan Jian, Nian Liu, Yan-Ru Zhang, Wen Gao, Wen-Ming Chen, Hong-Hu Zhu, Yin Wu
Journal: Blood (2023)
Bone Marrow Cellularity at Diagnosis Predicts Outcomes of Patients with Myelodysplastic Syndrome with Allogeneic Hematopoietic Stem Cell Transplantation
Authors: Seo-Yeon Ahn, Mihee Kim, Ga-Young Song, Sung-Hoon Jung, Jae-Sook Ahn, Deok-Hwan Yang, Je-Jung Lee, Hyeoung-Joon Kim
Journal: Blood (2023)
Generation of Bi-Specific Chimeric Antigen Receptor (CAR) T Cell Therapy for the Treatment of AIDS-Related B Cell Malignancies from Healthy Donors and HIV Patients
Authors: Saghar Pahlavanneshan, Ryan Urak, Ryotaro Nakamura, John Zaia, John H. Baird, Mary C Clark, Stephen J. Forman, Xiuli Wang
Journal: Blood (2023)
A Predictive Model Combining Clinical Characteristics and Nutritional Risk Factors for Overall Survival after Umbilical Cord Blood Transplantation
Authors: Meijuan Tu, Aijie Huang, Lijuan Ning, Baolin Tang, Chunli Zhang, Guangyu Sun, Xiang Wan, Kaidi Song, Wen Yao, Ping Qiang, Yue Wu, Xiaoyu Zhu
Journal: Blood (2023)
Improvement of Treatment-Free Remission Rate Following Discontinuation of BCR::ABL1 Tyrosine Kinase Inhibitors in Chronic Phase, Chronic Myeloid Leukemia
Authors: Sewon Lee, Hongtae Kim, Semin Lee, Seunghoon Kim, Sung-Ho Park, Sung-Hyun Kim, Young Rok Do, Soo-Hyun Kim, Kyung-Mi Kee, Dong-Wook Kim
Journal: Blood (2023)
Traceability and Characteristic Investigation of <i> <i>Burkholderia Gladioli</i> </i> Bloodstream Infection in Patients with Hematologic Malignancies
Authors: Lan Yao, Chenjing Qian, Jingjing Guo, Hongyong Zhang, Zixuan Li, Dairong Xie, Linghui Xia, Qiuling Wu, Mei Hong
Journal: Blood (2023)
Patient Preferences and Treatment Satisfaction in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Treated with Crovalimab and Approved C5 Inhibitors in the Phase III Randomized COMMODORE 1 and COMMODORE 2 Trials
Authors: Austin Kulasekararaj, Fernando Ataulfo Gonzalez Fernandez, Phillip Scheinberg, Nicole Straetmans, Yasutaka Ueda, Brittany Gentile, Jennifer Stefani, Marianne Uguen, Alexander Roeth
Journal: Blood (2023)
Anti-PD-1 Antibody (Tislelizumab) Combined with R-CHOP for the Treatment of Previously Untreated Primary Mediastinal B-Cell Lymphoma: A Prospective Phase II Study
Authors: Mei Wu, Lin Zhu, Shan Li, Tuerde Jiaerbao, Shanshan Wang, Xiao Liang, Xin Hu, Li Guo, Abulikemujiang Adili, Xianmusiya Maimaitirexiati, Ruirui Ren, Zhihua Yao, Shuna Yao, Shujuan Wen
Journal: Blood (2023)
Identification of Individual Risk Factors for Treatment Free Remission (TFR) Failure in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients: Predictive Models Developed on a Nationwide Clinical and Claim Database
Authors: Jules Chassetuillier, Meriem Benmerad, Pierre-Louis Lecoq, Romain Favier, Matthieu Trancart, Sandrine Hayette, Vincent Alcazer, Christophe Bouvier, Julien Bollard, Audrey Lajoinie, Franck E. Nicolini
Journal: Blood (2023)
Post Transplant Cyclophosphamide (PTCY) in Peripheral Blood Stem Cell Transplant Results in Successful Engraftment and Substantially Low Frequency of Chronic Graft Versus Host Disease (GvHD), without Impaired Cellular Immune Reconstitution
Authors: Ifigeneia Tzannou, Ioannis Tsonis, Tatiana Tzenou, Ekaterini Souravla, Maria Katsareli, Natali El Gotmi, Ismini Darmani, Evrydiki Theodorou, Maria Eleni Karatza, Maria Garofalaki, Zoi Poulopoulou, Marina Papageorgiou, Soultana Tryfonidou, Panagiotis Siamatas, Eirini Tziotziou, Eirini Grispou, Stavros Gigantes, Ioannis Baltadakis
Journal: Blood (2023)
Combining Inotuzumab Ozogamicin (IO) with PARP Inhibitors, Olaparib and Talazoparib, Exerts Synergistic Cytotoxicity By Inhibiting the Repair of IO-Induced DNA Strand Breaks in IO-Resistant ALL Cells
Authors: Naoko Ida, Miyuki Okura, Naoko Hosono, Takahiro Yamauchi
Journal: Blood (2023)
Real-World Analysis of Treatment Patterns and the Effectiveness and Safety Profile of Daratumumab-Based Regimens in Chinese Patients with Newly Diagnosed or Relapsed/Refractory Multiple Myeloma
Authors: Luqun Wang, Wei Yang, Yafei Wang, Ting Niu, Rong Fu, Yuping Zhong, Wenbin Qian, Kaiyang Ding, Kai Sun, Hong Liu, Baijun Fang, Hui Liu, Yanhui Li, Yishen Yang, Jianmin Zhuo, Xi Chen, Canchan Cui, Jin Lu
Journal: Blood (2023)
A New t(7;9)(p12;q34) Involving <i>NOTCH1</i> and <i>IKZF1</i> in Pediatric T-Cell Lymphoblastic Lymphoma
Authors: Frederic Paul Baleydier, Esther Amruthalingam, Marc Ansari, Anne-Laure Rougemont, David Hediger, Joelle Tchinda
Journal: Blood (2023)
Safety and Efficacy of Flumatinib in Patients with Chronic Myeloid Leukemia Resistant or Intolerant to Imatinib
Authors: Yuntao Liu, Yunfan Yang, Hui Sun, Li Meng, Hai Lin, Chunyan Chen, Jianda Hu, Xuliang Shen, Minghui Duan, Yanli Zhang, Dilinazi Abulaiti, Jinghua Wang, Hongqian Zhu, Luoming Hua, Qing Leng, Chun Zhang, Lili Sun, Weiming Li, Huanling Zhu, Bingcheng Liu, Jianxiang Wang
Journal: Blood (2023)
A Phase I/II, Intra-Patient Dose-Escalation Study of Bitopertin, a Selective Inhibitor of GlyT1 and Heme Synthesis, for Steroid-Refractory Diamond-Blackfan Anemia
Authors: David J. Young, Tania Rene Machado, Raymond T. Doty, Colin O. Wu, Janis L. Abkowitz, William Savage, Cynthia E. Dunbar
Journal: Blood (2023)
Epidemiology and Survival of Patients with Marginal Zone Lymphoma Treated at the National Cancer Institute of Peru. a Retrospective Analysis of 187 Cases
Authors: Jule F Vasquez, Jessica Meza, Melanie Wendy Castro-Mollo, Estefanía Peña-López, Lourdes ISABEL Lopez Chavez, Victor IVAN Mallma Soto, Cindy Alcarraz, Tatiana Vidaurre, Shirley Quintana
Journal: Blood (2023)
Low-Dose Decitabine Plus Venetoclax As Post-Transplant Maintenance for High-Risk Myeloid Malignancies
Authors: Katherine Parks, Kendall Diebold, Donna Salzman, Antonio Di Stasi, Manuel Espinoza-Gutarra, Ravi Bhatia, Zaid Al-Kadhimi, Omer Jamy
Journal: Blood (2023)
Idecabtagene Vicleucel (ide-cel) Versus Standard (std) Regimens in Patients (pts) with Triple-Class-Exposed (TCE) Relapsed and Refractory Multiple Myeloma (RRMM): Analysis of Cytopenias and Infections in Pts from KarMMa-3
Authors: Rachid Baz, Paula Rodriguez Otero, Sikander Ailawadhi, Bertrand Arnulf, Krina K. Patel, Ajay K. Nooka, Luciano Costa, Noopur S. Raje, Ingerid Weum Abrahamsen, Michel Delforge, Usama Gergis, Douglas W. Sborov, Sergio A. Giralt, Marc S. Raab, Tadao Ishida, Asya Varshavsky-Yanovsky, Taewoong Choi, Larry D. Anderson, Anna Truppel-Hartmann, Rashmi Bhatnagar, Fan Wu, Julia Piasecki, Jasper Felten, Andrea Caia, Mark Cook, Yi Lin
Journal: Blood (2023)
Anticoagulation for Splanchnic Vein Thrombosis in Patients with Myeloproliferative Neoplasms: A Systematic Review and Meta-Analysis
Authors: Pavlina Chrysafi, Kevin Barnum, Genevieve Gerhard, Thita Chiasakul, Arshit Narang, Megan McNichol, Nicoletta Riva, Walter Ageno, Jeffrey I. Zwicker, Rushad Patell
Journal: Blood (2023)
Long-term Follow-up from Qualitative Interviews of Patients with Relapsed or Refractory Large B-Cell Lymphoma on Their Treatment Experience While Enrolled in a Lisocabtagene Maraleucel Study
Authors: Pere Barba, Sally Lanar, Fei Fei Liu, Laurie Eliason, Kshawna Askew, Jennifer Devlen, Ulrika Furustrand, Ana Kostic
Journal: Blood (2023)
Cytarabine Plus Etoposideis+Peg-Rhg-CSF Is More Effective Than Cyclophosphamide + G-CSF As a Stem Cell Mobilization Regimen in Poorly Mobilized MM and Lymphoma
Authors: Yixuan Cheng, Dong Chen, Renzhi Pei, Xiaohong Du, Chen Li, Xianxu Zhuang, Fenglin Li, Peipei Ye, Ying Lu
Journal: Blood (2023)
Whole-Genome Sequencing Reveals Distinct Mutational Signatures in Multiple Myeloma Patients with African Ancestry Compared with Those of Non-African Ancestry
Authors: Kylee H Maclachlan, Patrick Blaney, Anthony Cirrincione, Timothy R. Chu, Alexandra Maria Poos, Elizabeth E. Brown, Elisabet E. Manasanch, Antje Hoering, Liming Hou, Dylan Gagler, Yubao Wang, Sanxiong Liu, Benjamin Diamond, Bachisio Ziccheddu, Marc S. Raab, Niels Weinhold, Ola Landgren, Nicolas Robine, Faith E. Davies, Alexander Lesokhin, Saad Z Usmani, Francesco Maura, Gareth J. Morgan
Journal: Blood (2023)
Clinical Results of a Randomized Placebo Controlled Trial of Inhaled Mometasone to Promote Reduction in Vaso-Occlusive Events (IMPROVE-II)
Authors: Susanna Curtis, Elizabeth Stidham, Robyn T. Cohen, Angela Liu, Marc Probst, Tiffany Mitchell, George Loo, Jordan Bellis, Chiemika Ihiasota, Jeffrey A. Glassberg
Journal: Blood (2023)
Deliriogenic Medication Use in Older Adults Receiving CAR-T Correlates with Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS)
Authors: Michael J. Maranzano, Justin Cheng, John Timmerman, Patricia A. Young, Caspian H. Oliai, Herbert A. Eradat, Sven de Vos, Sarah M. Larson, Monica Mead
Journal: Blood (2023)
Short-Term Efficacy and Safety of Blinatumomab in Early Postinduction Intensification Therapy for Pediatric B-Cell Acute Lymphoblastic Leukemia
Authors: Yanming Li, Peijing Qi, Ying Wu, Jiaole Yu, Yuanyuan Zhang, Huiqing Liu, Bei Hou, Jie Yang, Huyong Zheng, Tianyou Wang, Ruidong Zhang
Journal: Blood (2023)
Identification of Clinical-Biological Features of Newly Diagnosed Early Relapse Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation
Authors: Lorenzo Cillo, Anna Benedetta Dalla Palma, Matteo Scita, Federica Librale, Matia Bernardi, Stefania Ricci, Gabriella Sammarelli, Giannalisa Todaro, Mario Pedrazzoni, Nicola Giuliani
Journal: Blood (2023)
Long-Term Outcomes of T-Cell Acute Lymphoblastic Leukemia and Risk Factors for Survival in a Multicenter Registry Study from Brazil
Authors: Diego Luz, Bruno Kosa Lino Duarte, Yve Oliveira, Camila Piaia, Jordana S. R. Aragao, Ires Bezerra Massaut, Elvira Deolinda Rodrigues Pereira Velloso, Vanderson Rocha, Eduardo Magalhães Rego, Wellington F Silva
Journal: Blood (2023)
Establishment of Human Bone Marrow-on-Chip As a Preclinical Model to Evaluate Drug-Induced Toxicities and Myelofibrosis Patient-Specific Pathophysiology
Authors: Manti Guha, Ronald Dove, Aragaw Gebeyehu, Daniel Merenich, Paul Collier, Erin L. Crowgey, Mike Schaffer, Dana Shuey, Ricardo Macarrón, Alejandro Amador Arjona
Journal: Blood (2023)
North American Adult T-Cell Leukemia/Lymphoma Has Frequent Mutations in CCR4 and Responds in Vitro to a Small Molecule CCR4 Antagonist, CCR4-351
Authors: B. Hilda Ye, Eric Liu, Kith Pradhan, Erik Guillen, Urvi A Shah, Aditi Shastri, Gregoire Lauvau, Murali Janakiram, Alejandro Sica, Paul D. Kassner, Amit Verma
Journal: Blood (2023)
Molecular Findings on Plasma Cell-Free DNA Analysis Among Adults with Histiocytic Neoplasms
Authors: Gaurav Goyal, Aldo Adrian Acosta Medina, Jithma Prasad Abeykoon, Karen L Rech, Saurabh Zanwar, Aleksei Efremov, Danielle Sookiasian, Cagdas Tazearslan, Anastasia Yudina, Aishwarya Ravindran, Gordon J Ruan, Matthew J Koster, W. Oliver Tobin, Robert Vassallo, Jay Ryu, N. Nora Bennani, Mithun V Shah, Liuyan Jiang, Lucinda Gruber, Caroline Davidge-Pitts, Thomas E. Witzig, Jason R Young, Surendra Dasari, Ronald S. Go
Journal: Blood (2023)
The Treatment of Burkitt Lymphoma with the Berlin-Frankfurt-Münster Protocol with Rituximab and Autologous Transplantation
Authors: Alessandro Broccoli, Gianmarco Bagnato, Lisa Argnani, Beatrice Casadei, Martina Cantelli, Cinzia Pellegrini, Sabrina Zoli, Emanuele Sutto, Paolo Elia Coppola, Marianna Gentilini, Alice Morigi, Matteo Carella, Gabriele Gugliotta, Laura Nanni, Vittorio Stefoni, Pier Luigi Zinzani
Journal: Blood (2023)
Effectiveness and Safety of Hetrombopag-Containing Therapy in Patients with Severe Aplastic Anemia: A Multicenter Real-World Study
Authors: Hong Chang, Ling Pan, Yongqian Jia, Bing Xiang, Xiaoou Huang, Yong Guo, Meng Li, Hongyun Xing, Fang Xu, Ying Yuan, Ying Lian, Lihua Yang, Ting Niu
Journal: Blood (2023)
Real-World Evaluation of Treatment Patterns and Clinical Outcomes Among Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated with Asciminib in US Clinical Practice
Authors: Ehab L. Atallah, David Wei, Dominick Latremouille-Viau, Carmine Rossi, Andrea Damon, Germano Ferreira, Annie Guerin, Kejal Jadhav
Journal: Blood (2023)
Innovative Transformer Base Editor (tBE)-Mediated Editing at BCL11A Binding Motif Triggers High Level of γ-Globin Expression with No Observable Off-Target Mutations
Authors: Jia Chen, Wenyan Han, Hou-Yuan Qiu, Shangwu Sun, Zhi-Can Fu, Guo-Quan Wang, Li Yang, Bei Yang, Ying Zhang
Journal: Blood (2023)
Safety and Efficacy of a-319 (a CD3xCD19 T cell engager) in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Authors: Wei Ping Liu, Bo Jiang, Yue Rong Shuang, Xing Zhao, Xuan Fan Zhong, Ying Tan, Guo Jian Yu, Sheng Jie Xue, Wu Zhong Shen, Gui Yun Tu, Zheng Yang, Han Yang Chen, Jason Xu, Shui Liu, Xiao Qiang Qiang Yan, Jun Zhu, Yu Qin Song
Journal: Blood (2023)
HJKC3-0006: Outcome of Patients with CML Treated on Second Line or Later Therapy in Routine Clinical Practice
Authors: James E Thompson, Yan Gao, Alexis Visotcky, Kathryn E Flynn, Michael Mauro, Emily Giever, Arielle Baim, Idayat Akinola, Richard Larson, Omer Jamy, Anthony M. Hunter, Vamsi K. Kota, Jorge Cortes, Brian J. Druker, Neil P. Shah, Javier Pinilla-Ibarz, Jay Yang, Ellen K. Ritchie, Lindsay A.M Rein, B. Douglas Smith, Srinivas K. Tantravahi, Talha Badar, Michael W. Deininger, Ehab L. Atallah
Journal: Blood (2023)
Philadelphia-like B-Cell Acute Lymphoblastic Leukemia in a Largely Hispanic Population: Disease Features and Outcomes in the Era of Immunotherapy a Single Institutional Study
Authors: Karam Ashouri, Brian Hom, Yekta Rahimi, Karen Resnick, Vinay Nittur, Jennifer Hwang, Blake Adnani, Mollee Chu, Anush Aram Ginosyan, Robert Ireland, Eljie Isaak Bragasin, Shirley Ye, Lakshmi Savitala-Damerla, Kimberly Schiff, Preet M. Chaudhary, Imran Siddiqi, Abdullah Ladha, Amir Ali, Karrune Woan, Eric Tam, George Yaghmour
Journal: Blood (2023)
<i>Ex Vivo</i> Treatment By Mitapivat, an Allosteric Pyruvate Kinase Activator, Reduced Oxidative Stress and Promoted Terminal Erythropoiesis in a Severe Hemolytic Anemia Patient Due to Krϋppel-like Factor 1 Mutations
Authors: Thidarat Suksangpleng, Kalaya Tachavanich, Vip Viprakasit
Journal: Blood (2023)
Letermovir Prophylaxis for Cytomegalovirus Reactivation in β Thalassemia Major Children after Hematopoietic Cell Transplantation
Authors: Lingling Shi, Rongrong Liu, Zhongming Zhang, Cuifeng Huang, Lianjin Liu, Yibin Yao, Zhenbin Wei, Shuyi Wei, Zhaoping Gan, Na Sun, Beicai Liu, Rui Huang, Xuemei Zhou, Yinghua Chen, Qifa Liu, Yongrong Lai
Journal: Blood (2023)
Patients' Perception of Usability and Utility of a Digital Health Tool for Electronic Patient-Reported Outcomes Monitoring in Real-Life Hematology Practice: Evidence from the Gimema-Alliance Platform
Authors: Fabio Efficace, Mario Luppi, Leonardo Potenza, Francesco Sparano, Giovanni Caocci, Francesca Fazio, Massimo Breccia, Maria Teresa Petrucci, Andrea Patriarca, Thomas Baldi, Michelina Santopietro, Roberta Battistini, Agostino Tafuri, Gloria Margiotta Casaluci, Elisabetta Colaci, Davide Giusti, Valeria Pioli, Paolo De Fabritiis, Nicolina Rita Ardu, Pasquale Niscola, Olga Mulas, Claudio Fozza, Sergio Siragusa, Salvatrice Mancuso, Paola Boggione, Lorenzo De Paoli, Anna Paola Leporace, Maria Paola Bianchi, Ida Carmosino, Claudio Cartoni, Alice Di Rocco, Isabella Capodanno, Massimo Pini, Alessandra Romano, Paola Fazi, Marco Vignetti
Journal: Blood (2023)
Arsenic Trioxide Combine with G-CSF Triggers Distinct TP53 Mutations Acute Myeloid Leukemia Cells Ferroptosis through TP53-SLC7A11-GPX4 Pathway
Authors: Gelan Zhu, Wanbin Fu, Lan Xu, Yiwei Zhang, Jiong Hu, Jian Hou, Hua Zhong
Journal: Blood (2023)
Epitope Edited Hematopoietic Stem Cells Allow Immune-Based In Vivo Selection of Genome-Engineered Cells
Authors: Gabriele Casirati, Andrea Cosentino, Adele Mucci, Mohammed S Mahmoud, Marta Freschi, Jing Zeng, Christian Brendel, Daniel E. Bauer, Pietro Genovese
Journal: Blood (2023)
The Role of Small Nucleolar RNAs As Putative Biomarkers of Chemoresistance in Pediatric Acute Lymphoblastic Leukemia
Authors: Olga Krali, Anna Pia Enblad, Kristin Blom, Claes Andersson, Britt-Marie Frost, Josefine Palle, Arja Harila, Olli Lohi, Erik Forestier, Jukka Kanerva, Trond Flægstad, Ólafur G Jónsson, Kjeld Schmiegelow, Mats Heyman, Peter Nygren, Rolf Larsson, Gudmar Lönnerholm, Jessica Nordlund
Journal: Blood (2023)
Outcomes of Tcrαβ and CD19-Depleted Hematopoietic Stem Cell Transplantation from Matched, Mismatched Unrelated and Haploidentical Donors for Pediatric Patients with Hematological Malignancy: A Meta-Analysis
Authors: Hussien Ahmed H. Abdelgawad, Heba Aboeldahab, Mohamed Mohamed Belal, Mohamed Nabih Bashir, Mario Otto
Journal: Blood (2023)
Upfront Allogeneic Hematopoietic Stem Cell Transplantation Can Provide Survival Benefit Versus Hypomethylating Agent in Myelodysplastic Syndrome with Increased Blasts I (MDS-IB I)
Authors: Runzhi Ma, Sisi Zhen, Li Liu, Jieru Wang, Erlie Jiang, Sizhou Feng
Journal: Blood (2023)
Lncrna <i>Famlf-2</i> Promotes Leukemogenesis Via the DHX9/c-Myc Axis in Acute Lymphoblastic Leukemia
Authors: Xiaolin Lai, Yuanhua Cai, Yuanmao Huang, Shuiling Shi, Zhixiang Chen, Xuechun Wang, Fuquan Tu, Luya Ye, Xiaofan Li, Lili PAN, Jinggang Li, Yang Li, Huiying Gao, Shaoyuan Wang
Journal: Blood (2023)
Predictive Biomarkers of Response to Luspatercept in Patients with Myelofibrosis- (MF) Associated Anemia: Biomarker Analysis from the ACE-536-MF-001 Study
Authors: Danny Jeyaraju, Sheida Hayati, Niloufar Marsousi, Aaron T. Gerds, Francesco Passamonti, Fabian Sanabria, Sadanand Vodala, Anita K. Gandhi, Rajasekhar N.V.S. Suragani
Journal: Blood (2023)
The Impact of Cardiovascular Vulnerabilities in Non Hodgkin Lymphoma Patients Treated with Chimeric Antigen Receptor T Cell Therapy
Authors: Ivan Landego, Jessica R Flynn, Adam Goldman, Sean M. Devlin, Efrat Luttwak, Alejandro Luna De Abia, Magdalena Corona, Meirav Kedmi, Inbal Sdayoor, Shalev Fried, Noga Shem-Tov, Avichai Shimoni, Ivetta Danylesko, Mohammad Hammoud, Ronit Yerushalmi, Arnon Nagler, Ronit Marcus, Ahmed El-Moghraby, Mahin Rehman, Parastoo B. Dahi, Sergio A. Giralt, Richard J. Lin, Maria Lia Palomba, Michael Scordo, Gunjan L. Shah, Miguel-Angel Perales, Syed Mahmood, Abraham Avigdor, Jennifer Liu, Roni Shouval
Journal: Blood (2023)